Smarter Biomanufacturing: Evaluating the Risks and Opportunities
Advances in manufacturing 4.0 including digitalization, AI, and machine learning offer biopharmaceutical company's unique opportunities to overhaul antiquated processes to increase productivity, flexibility, and reduced cost. However, as with each great innovation, there are risks, uncertainties, and challenges. Our experts share their individual experiences and insight to help your anticipate challenges and implement better manufacturing strategies to accelerate success.
Cambridge Healthtech Institute keeps the life science community connected and delivers the latest research, science, and solutions for exploring the future of precision medicine, diagnostics and innovative technologies… all without leaving your ...